KTTA - Pasithea Therapeutics Corp.
1.52
0.100 6.579%
Share volume: 225,336,409
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.42
0.10
0.07%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-12-2023 | 08-11-2023 | 11-13-2023 | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-24-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 3.213 M | 3.829 M | 3.789 M | 4.041 M | 3.945 M | 3.005 M | 3.260 M | |
| Selling general and admin | 2.116 M | 1.801 M | 2.165 M | 2.292 M | 1.587 M | 1.423 M | 1.750 M | |
| Research and development | 1.096 M | 2.028 M | 1.625 M | 1.749 M | 2.358 M | 1.581 M | 1.510 M | |
| Total expenses | 3.213 M | 3.829 M | 3.789 M | 4.041 M | 3.945 M | 3.005 M | 3.260 M | |
| 19.18% | -1.03% | 6.64% | -2.37% | -23.84% | 8.49% | |||
| Operating income | -3.213 M | -3.829 M | -3.789 M | -4.041 M | -3.945 M | -3.005 M | -3.260 M | |
| Ebit | -3.213 M | -3.829 M | -3.789 M | -3.861 M | -3.866 M | -3.070 M | -3.531 M | |
| Pretax income | -3.266 M | -3.598 M | -3.613 M | -3.861 M | -3.866 M | -3.000 M | -3.178 M | |
| 10.17% | 0.40% | 6.87% | 0.14% | -22.41% | 5.93% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -3.538 M | -3.763 M | -3.613 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| -6.38% | 4.00% | 100.00% | ||||||
| Net income | -3.538 M | -3.763 M | -3.613 M | -3.861 M | -3.866 M | -3.000 M | -3.178 M | |
| -6.38% | 4.00% | -6.87% | -0.14% | 22.41% | -5.93% |
